Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Comparison Study of Letrozole Alone or Letrozole With Zoledronic Acid in Early Breast Cancer, Neoadjuvant Therapy

This study has been completed.
Sponsor:
Information provided by:
Novartis
ClinicalTrials.gov Identifier:
NCT00247650
First received: November 1, 2005
Last updated: November 20, 2009
Last verified: November 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: March 2007 (Final data collection date for primary outcome measure)